H19 and colorectal carcinoma: The present work reveals a novel regulatory pathway of H19/miR-194–5p/SIRT1/autophagy in 5-Fu resistance of CRC cells, suggesting that H19 is a new prognostic factor and potential therapeutic target in CRC.